JPRN-UMIN000052759
Not yet recruiting
Phase 2
Phase II study to examine the efficacy and safety of Awa Suzuka extracted ingredients - Phase II study of Awa Suzuka extracted ingredients
Tokushima University Graduate School0 sites40 target enrollmentNovember 10, 2023
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Healthy subjects with serum triglyceride levels in the borderline range
- Sponsor
- Tokushima University Graduate School
- Enrollment
- 40
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Persons with diseases of the liver, kidney, heart, etc. Those who are taking medication for the purpose of treatment of diseases such as lifestyle\-related diseases Those who have taken supplements within 1 month of the start of the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Evaluation of the efficacy of bioadhesive barrier-forming oral liquid gel (Episil) for prevention of oral mucositisJPRN-jRCTs062220023Takano HIdeyuki50
Recruiting
Phase 2
Phase II study of multimodality treatment for ATRTAtypical teratoid rhabdoid tumorD016543JPRN-jRCTs051200071Junichi Hara50
Recruiting
Phase 2
Phase II study of new risk classification and high-dose chemotherapy for medulloblastomaJPRN-jRCTs051200021Hara Junichi229
Not yet recruiting
Phase 2
Phase II study to evaluate the efficacy and safety of mirogabalin for CIPN in patients with gastrointestinal cancer.esophageal cancer, gastric cancer, small bowel cancer, colon cancer, pancreatic cancerJPRN-UMIN000049555ational Cancer Center Hospital30
Recruiting
Phase 2
Phase II study to investigate efficacy and safety of erlotinib in patients with advanced and recurrent NSCLC with poor performance statusJPRN-UMIN000003540Yamaguchi Thoracic Oncology Group(YTOG)20